Artwork

Content provided by Austrade Hong Kong. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Austrade Hong Kong or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep.15: Main Sequence Ventures: Commercialising Deep Science

36:17
 
Share
 

Archived series ("Inactive feed" status)

When? This feed was archived on October 08, 2022 08:06 (1+ y ago). Last successful fetch was on August 03, 2021 22:08 (2+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 207914561 series 2332453
Content provided by Austrade Hong Kong. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Austrade Hong Kong or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode Sam speaks with Mike Zimmerman of Main Sequence Ventures, CSIRO's VC fund. Mike explains MSV's focus on commercialising world-class Australian deep science R&D. Mike previews the remarkable companies and founders in next gen WiFi, cancer diagnosis, AI and Big Data already within the MSV portfolio and talks about why the fund is looking to Asia, and HK for additional investment.
For more information about Main Sequence Ventures, please visit https://mseq.vc/
  continue reading

22 episodes

Artwork
iconShare
 

Archived series ("Inactive feed" status)

When? This feed was archived on October 08, 2022 08:06 (1+ y ago). Last successful fetch was on August 03, 2021 22:08 (2+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 207914561 series 2332453
Content provided by Austrade Hong Kong. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Austrade Hong Kong or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode Sam speaks with Mike Zimmerman of Main Sequence Ventures, CSIRO's VC fund. Mike explains MSV's focus on commercialising world-class Australian deep science R&D. Mike previews the remarkable companies and founders in next gen WiFi, cancer diagnosis, AI and Big Data already within the MSV portfolio and talks about why the fund is looking to Asia, and HK for additional investment.
For more information about Main Sequence Ventures, please visit https://mseq.vc/
  continue reading

22 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide